MediWound Forecasts 65-Cent Loss, 21% Revenue Drop Ahead of Q1 Report
Reported by Reuters
Sentiment
Negative
Importance
7
Price
$16.58
Mkt Cap
$212.981M
52W Low
$14.9
52W High
$22.505
Market data snapshot near publication time
Summary
Analysts expect MediWound to report a loss of 65 cents per share and a 21.2% revenue decrease to $3.117 million for the first quarter of 2026. This earnings preview precedes the company's official Q1 report scheduled for May 27. The projected significant decline in revenue suggests potential headwinds for the company. Traders will be watching the actual Q1 results closely to see how they compare to these analyst expectations.
At the time of this announcement, MDWD was trading at $16.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $213M. The 52-week trading range was $14.90 to $22.51. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.